Citius Pharmaceuticals Inc.
CTXR | NASDAQ
$0.58
-$0.02 (-3.33%)
At close: Sep 21, 2026, 4:00 PM ET
$0.58
$0 (-0.60%)
Pre-market:
Sep 22, 2026, 8:55 AM ET
TTM Period Ending | Q3 2026 Jun 29, 2026 | Q2 2026 Mar 30, 2026 | Q1 2026 Dec 30, 2025 | Q4 2025 Sep 29, 2025 | Q3 2025 Jun 29, 2025 | Q2 2025 Mar 30, 2025 | Q1 2025 Dec 30, 2024 | Q4 2024 Sep 29, 2024 | Q3 2024 Jun 29, 2024 | Q2 2024 Mar 30, 2024 | Q1 2024 Dec 30, 2023 | Q4 2023 Sep 29, 2023 | Q3 2023 Jun 29, 2023 | Q2 2023 Mar 30, 2023 | Q1 2023 Dec 30, 2022 | Q4 2022 Sep 29, 2022 | Q3 2022 Jun 29, 2022 | Q2 2022 Mar 30, 2022 | Q1 2022 Dec 30, 2021 | Q4 2021 Sep 29, 2021 | Q3 2021 Jun 29, 2021 | Q2 2021 Mar 30, 2021 | Q1 2021 Dec 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 7.11M | 5.61M | 3.94M | n/a | 155.93K | 155.93K | 155.93K | 155.93K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 3.97M | 3.52M | 1.47M | 103.41K | 197.29K | 208.77K | 260.84K | 311.85K | 205.9K | 202.06K | 198.14K | 194.32K | 190.6K | 186.93K | 183.26K | 179.68K | 176.2K | 172.53K | 168.65K | 164.87K | 122.1K | 80.42K | 39.82K |
Gross Profit | 3.14M | 2.1M | 2.48M | -103.41K | -95.05K | -106.53K | -158.6K | -209.61K | -205.9K | -202.06K | -198.14K | -194.32K | -190.6K | -186.93K | -183.26K | -179.68K | -176.2K | -172.53K | -168.65K | -164.87K | -122.1K | -80.42K | -39.82K |
Operating Income | -60.89M | -58.44M | -37.51M | -38.53M | -41.14M | -42.98M | -42.69M | -42M | -41.07M | -39.11M | -38.82M | -36.73M | -34.16M | -34.4M | -31.31M | -33.32M | -30.97M | -28.04M | -24.63M | -23.53M | -22.47M | -21.17M | -21.42M |
Interest Income | 268.8K | 172.74K | 132.57K | 110.08K | 173.97K | 358.18K | 526.97K | 758K | 965.5K | 1.1M | 1.22M | 1.18M | 989.43K | 705.67K | 431.97K | 251.4K | 192.17K | 242.57K | 282.32K | 261.83K | 209.83K | 119.43K | 62.21K |
Pretax Income | -57.98M | -54.89M | -37.8M | -38.68M | -41.14M | -42.63M | -39.78M | -38.85M | -37.72M | -35.62M | -37.6M | -31.97M | -29.58M | -30.11M | -27.29M | -33.06M | -30.61M | -27.57M | -24.13M | -23.05M | -22.21M | -21.07M | -21.37M |
Net Income | -49.33M | -46.2M | -35.89M | -37.43M | -40.26M | -42.05M | -39.68M | -39.14M | -38.29M | -36.2M | -38.18M | -32.54M | -30.59M | -30.92M | -27.93M | -33.56M | -30.53M | -27.54M | -24.13M | -23.05M | -22.21M | -21.07M | -21.37M |
Selling & General & Admin | 39.45M | 40.46M | 21.57M | 23.76M | 30.71M | 31.41M | 31.28M | 30.09M | 29.2M | 26.23M | 24.83M | 21.91M | 18.36M | 17.48M | 15.66M | 15.66M | 14.88M | 14.63M | 13.13M | 11.29M | 11.04M | 9.3M | 9.08M |
Research & Development | 5.93M | 6.5M | 8.63M | 9.16M | 10.43M | 11.57M | 11.41M | 11.91M | 11.87M | 12.88M | 14M | 14.82M | 15.79M | 16.92M | 15.64M | 17.66M | 16.09M | 13.41M | 11.51M | 12.24M | 11.43M | 11.87M | 12.34M |
Other Expenses | 18.66M | 13.57M | 9.79M | 5.51M | -41.37K | n/a | -52.07K | -52.07K | -52.07K | -52.07K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 59.92K | 59.92K | 59.92K | 59.92K | n/a | n/a |
Operating Expenses | 64.03M | 60.54M | 39.98M | 38.42M | 41.1M | 42.98M | 42.64M | 41.94M | 41.02M | 39.06M | 38.82M | 36.73M | 34.16M | 34.4M | 31.31M | 33.32M | 30.97M | 28.04M | 24.63M | 23.53M | 22.47M | 21.17M | 21.42M |
Interest Expense | 52.36K | 456.35K | 423.32K | 267.78K | 172.26K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.93K | 6.87K | 10.84K | 14.3K | 15.61K | 15.65K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 68M | 64.05M | 41.45M | 38.53M | 41.14M | 42.98M | 42.69M | 42M | 41.07M | 39.11M | 38.82M | 36.73M | 34.16M | 34.4M | 31.31M | 33.32M | 30.97M | 28.04M | 24.63M | 23.53M | 22.47M | 21.17M | 21.42M |
Income Tax Expense | 189.92K | 561.51K | 1.06M | 1.06M | 936.72K | 816.48K | 696.24K | 576K | 576K | 576K | 576K | 576K | 1.01M | 864K | 720K | 576K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 26.17M | 22.38M | 21.5M | 18.07M | 11.01M | 11.59M | 11.59M | 11.59M | 11.59M | 10.6M | 10.6M | 10.59M | 10.25M | 9.75M | 9.75M | 9.74M | 9.74M | 9.74M | 9.73M | 9.73M | 9.14M | 6.4M | 3.71M |
Shares Outstanding (Diluted) | 26.17M | 22.38M | 21.5M | 18.07M | 11.01M | 11.59M | 11.59M | 11.59M | 11.59M | 10.6M | 10.6M | 10.59M | 10.25M | 9.75M | 9.75M | 9.74M | 9.74M | 9.74M | 9.73M | 9.76M | 9.14M | 6.4M | 3.71M |
EPS (Basic) | -2.11 | -2.57 | -2.89 | -3.81 | -4.96 | -5.73 | -5.80 | -5.95 | -4.42 | -2.91 | -1.64 | -0.21 | -0.21 | -0.21 | -0.19 | -0.23 | -0.21 | -0.19 | -0.18 | -0.27 | -0.35 | -0.41 | -0.50 |
EPS (Diluted) | -2.11 | -2.57 | -2.89 | -3.81 | -5.07 | -5.84 | -5.91 | -6.06 | -4.42 | -2.91 | -1.64 | -0.21 | -0.21 | -0.21 | -0.19 | -0.23 | -0.21 | -0.19 | -0.18 | -0.27 | -0.35 | -0.41 | -0.50 |
EBITDA | -58.44M | -55.93M | -36.68M | -38.2M | -40.88M | -42.73M | -42.51M | -41.84M | -40.96M | -39.01M | -38.67M | -36.59M | -33.83M | -34.08M | -30.96M | -32.94M | -30.49M | -27.4M | -23.96M | -22.88M | -22.04M | -20.9M | -21.2M |
EBIT | -49.6M | -58.37M | -37.42M | -38.42M | -41.08M | -42.95M | -42.67M | -42M | -41.07M | -39.11M | -38.82M | -36.73M | -34.02M | -34.27M | -31.17M | -33.18M | -30.73M | -27.63M | -24.16M | -23.04M | -22.2M | -21.05M | -21.36M |
Depreciation & Amortization | 2.4M | 2.44M | 732.85K | 214.25K | 205.9K | 217.38K | 213.44K | 209.61K | 205.9K | 202.06K | 198.14K | 194.32K | 190.6K | 186.93K | 183.26K | 179.68K | 176.2K | 172.53K | 168.65K | 164.87K | 161.23K | 150.58K | 157.44K |
Add to Watchlist
Select watchlists to add or remove CTXR